Prognostic Impact of Mineralocorticoid Receptor Antagonist in Patients with Heart Failure with Preserved Ejection Fraction

Abstract

Mineralocorticoid receptor antagonist use was significantly associated with a lower risk of the primary composite outcome of cardiovascular death and HF readmission in patients hospitalized for acute decompensated HFpEF. The incidence of cardiovascular mortality was also significantly lower in these patients.